|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||78.55 - 79.35|
|52-week range||52.51 - 80.71|
|PE ratio (TTM)||29.74|
|Earnings date||14 Feb 2018 - 19 Feb 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||77.35|
UnitedHealth Group’s Optum health services unit is now in half of the 75 U.S. markets executives targeted for expansion.
UnitedHealth’s quarterly profit beat analysts’ expectations and the health insurer raised its yearly outlook, as revenue from both its health care and health care services businesses increased.
DaVita (DVA) collaborates with Epic to introduce electronic health record facility for patients, reduce costs and enhance healthcare.
A Texas-based pharmacy chain that specializes in patients with kidney problems will pay nearly $64 million to settle allegations of improper billing and other disputed financial practices. Federal prosecutors ...
After a divestiture deal that could raise nearly $5 billion for kidney dialysis leader DaVita (DVA) is now 13% higher than the level where Barron's warned that insurers were attacking DaVita's profits ("Insurers Press Dialysis Claims," September 2, 2017). Bulls like John Ransom at Raymond James expect the company to repurchase stock and pay down debt with the proceeds from a December 6 deal to sell its medical practices to UnitedHealth Group (UNH). On December 7, the Raymond James analyst raised his rating on DaVita shares from Outperform to a Strong Buy, while upping his price target from $65 to $84.
The Dow endured a volatile week even as Republicans tasted success on the tax legislation front.
UnitedHealth's (UNH) intention to buy DaVita Medical reflects its continuous effort to build up a vertically integrated business model
As CVS Health and Aetna seek to build an integrated health care company without doctors, rival UnitedHealth Group makes $4.9 billion deal to add more providers.
DaVita (DVA) soared to the top of the S&P 500 today after it sold its Medical Group for nearly $5 billion to UnitedHealth Group (UNH). DaVita gained 14% to $69.20 today, while the S&P 500 finished little changed at 2629.27. UnitedHealth dipped 0.1% to $219.94.
Stocks that moved substantially or traded heavily Wednesday: DaVita Inc., up $8.27 to $69.20 The dialysis services company agreed to sell a physician practice business to health insurer UnitedHealth for ...
Health insurers are trying to cut medical costs by playing a more direct role in medical services, arguing they can save money by shifting patients to cheaper, more accessible locations for routine or non life-threatening emergency medical services. On Sunday, No. 3 health insurer Aetna Inc agreed to be bought by CVS Health as part of a drive to expand medical services at CVS pharmacies to include more preventative screenings such as for vision and hearing.
UnitedHealth announced Wednesday that it would by dialysis center DaVita's medical unit for $4.9 billion in cash.
The nation's biggest health insurer is spending nearly $5 billion to buy hundreds of clinics, just three days after rival Aetna announced a bigger tie up with CVS Health Corp. UnitedHealth Group Inc. said ...
On Wednesday, only a few days after the CVS (CVS) and Aetna (AET) deal helped shine a light on the quickly changing healthcare industry, UnitedHealth Group (UNH) announced that it will buy a unit of DaVita Inc. (DVA) for nearly $5 billion.
Among the companies with shares expected to trade actively in Wednesday's session are Apple, Alphabet, Home Depot, DaVita and Walgreens Boots Alliance.
Stocks were poised for a lower open Wednesday, following third-quarter productivity data and a surge in bitcoin past $12,000, which now makes it bigger than all but 16 S&P 500 components. S&P 500 futures were down 0.1% ahead of the open. The Dow Jones Industrial Average futures and Nasdaq futures were both off 0.3%.